Is one beta blocker better than another for patients born with long QT syndrome?
In a report published Sept 23 in The Journal of the American College of Cardiology Abeer Abu-Zeitone, PhD, and colleagues found that in their study group, nadolol worked best at preventing a recurrent serious cardiac event and that propranolol, the oldest beta-blocker available, did the worst. The researchers also evaluated how patients had fared with atenolol and metoprolol.
But in an editorial commenting on the findings, Arthur Wilde, MD, PhD, and Michael Ackerman MD, PhD, questioned the study’s methodology and predicted that many heart centers will continue to use propranolol.
The American College of Cardiologists (ACC) has had a change of heart. The group is now recommending doctors treating heart attack patients for arterial blockages should treat lesions in both cardiac arteries, not just the “culprit” artery that led to the MI.
In a statement Sept. 22, the ACA cited new information—reported Sept. 5 by HCPLive.com—from a UK study showing that it pays to do the more extensive procedure.
Enterovirus-D68 could soon be in the rearview mirror, according to a Hartford, CT, pediatric intensivist who has treated more than 20 children hospitalized with the infection.
“We may have plateaued,” said Christopher Carroll, MD, an asthma specialist at Connecticut Children’s Medical Center. While children are still being admitted for respiratory problems, “Now it’s more a mix of symptoms, not those of classic enterovirus.”
Though he could not say for certain the outbreak has peaked, he did say that “things are not continuing to get worse.”